NEWS

2017

AMI-USC WILL BE A PLATINUM SPONSOR OF THE SOUTHERN CALIFORNIA BIOMEDICAL COUNCIL ANNUAL INVESTOR CONFERENCE

September 14, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that it will be a platinum sponsor of the 19th Annual SoCalBio Conference in Long Beach on September 29th.

Jon Lasch, AMI-USC’s Executive Director said, “Southern California Biomedical Council (SoCalBio) is a nonprofit, member-supported trade association that serves the biotech, medtech, IVD and digital health communities in the six counties that comprise the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino). We sponsor this conference because what they do – showcasing value-based bioscience innovations and exploring efficient pathways to bring them to market – lines up really well with what we do. It is also great to keep up with what Biomedical innovators are doing and share with them what we are doing.”

PROA MEDICAL, INC. ENTERS INTO STRATEGIC ALLIANCE AND NATIONWIDE DISTRIBUTION AGREEMENT WITH A LEADING WOMEN’S HEALTH DISTRIBUTOR

June 27, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that Proa Medical, Inc., an AMI-USC spinout company focused on women’s health medical devices, entered into a strategic alliance and nationwide distribution agreement with a leading women’s health distributor.

Arman Nadershahi, AMI-USC’s Senior Corporate and Intellectual Property Counsel, and CEO of Proa Medical, Inc., said, “We are excited to have formally entered into a long-term relationship with a preeminent distributor of obstetrical products. Our distributor has committed to investing considerable resources to market and sell Proa Medical’s innovative Brella Vaginal Retractor to hospitals throughout the US.”

The Brella Vaginal Retractor is a patented, single-use retractor with a built-in light source designed to provide optimal visualization and access during vaginal or perineal wound repair. The Brella lighted retractor separates the edges of the vagina, provides interior illumination, holds back tissue (including deep vaginal walls), and may reduce the incidence of needle stick injuries. Proa Medical, Inc. has received positive feedback from obstetricians and repeat hospital orders in its initial test launch.

About Proa Medical, Inc.

Proa Medical, Inc. provides a rapid and efficient channel to commercialize novel medical devices for women’s health that are easier to use, safer, and more efficient. As a spinout of the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (USC), the company was founded to help physician-inventors efficiently bring to market innovative, practice-enhancing technologies.

37 ºC 2017 OSLO, NORWAY CONFERENCE – JON LASCH PRESENTATION

Jon’s presentation may also be viewed here.

June 6, 2017

NANOENGINEERED STENT SURFACE TO REDUCE IN-STENT RESTENOSIS IN VIVO

June 2, 2017

VAROCTO RECEIVES APPROVAL FOR 3 PRODUCTS FROM CHINESE FDA

June 2, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that Varocto, Inc., an AMI ophthalmology spinout, received approval for 3 of its products from the Chinese equivalent of the FDA.

Winn Hong, AMI-USC’s Sr. Director for Engineering and Business Development, and Interim CEO of Varocto, said, “We are happy to report that Varocto’s products for high-resolution, non-invasive, retinal angiography have been approved by the Chinese FDA. These products include optical coherence tomography (OCT) hardware, angiography software, and a combination of the two. The products will help prevent blindness, through early diagnosis, in people with diabetic retinopathy, macular degeneration, macular edema and other potentially blinding diseases. The big news is that these products are part of a platform technology that mitigates these problems non-invasively in less than 2 minutes.”

AIMBE HAS ELECTED SEVEN FELLOWS FROM AMI-USC

May 18, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that the American Institute for Medical and Biological Engineering (AIMBE), a non-profit organization headquartered in Washington, DC that represents the top 2% of medical and biological engineers, elected seven of USC-AMI’s associates as fellows.

Jon Lasch, AMI-USC’s Executive Director said, “We are very happy and proud to report that AIMBE elected Cesar Blanco and Molly Schmid as Fellows. They join Scott Fraser, Rob Greenberg, David Hankin, Tom Lobl, and myself, who were previously elected. This is a great honor and very important since AIMBE helps to shape healthcare policy in the US and around the world.”

HELPING TO BRING LIFESAVING MEDICAL INVENTIONS TO MARKET

April 24, 2017